About Helmholtz Munich
Helmholtz Munich is a Healthcare company based in Munchen (Germany) founded in 1960. It operates as a provider of medical research lab and services. Its chief executive is Matthias H Tschop. Its website helmholtz-munich.de draws about 95 thousand monthly visits. Helmholtz Munich offers products and services including Diabetes Research and Environmental Health Analysis. Its focus areas include Medical Research Labs. Its legal entity is Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH).
Company details
Helmholtz Munich, established in 1960, excels in providing healthcare solutions, and medical research labs. Provider of medical research lab and services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Munchen, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website helmholtz-munich.de
- Social LinkedIn X Instagram YouTube
- Legal Name Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh)
- Latest Funding Round$173.82K (USD), Grant
Sep 2022
- Investors
Products & Services of Helmholtz Munich
Helmholtz Munich offers a comprehensive portfolio of products and services, including Diabetes Research and Environmental Health Analysis.
Research is performed on diabetes and related metabolic conditions to enhance understanding and develop preventive measures
Studies are conducted on environmental factors affecting health, such as allergies and epidemiology, to inform public health strategies
Apps and channels of Helmholtz Munich
its YouTube channel Helmholtz Munich has 999 subscribers and 30 videos.
Videos from Helmholtz Munich
The most watched videos on Helmholtz Munich's YouTube channel, Helmholtz Munich (999 subscribers). Click a video to play it here.
More on Helmholtz Munich.
Funding Insights of Helmholtz Munich
- Total Rounds 57
- Last Round Grant — $173,820
- Investors Count 1
Latest 10 of 57 funding rounds of Helmholtz Munich with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $173,820 | Grant | – | – | |
| Jan 2022 | $173,820 | Grant | – | – | |
| Jan 2022 | $194,898 | Grant | – | – | |
| Jan 2022 | $181,119 | Grant | – | – | |
| Sep 2021 | $5.66M | Grant | – | – | |
| Feb 2021 | – | Grant | – | – | |
| Dec 2020 | $427,629 | Grant | – | – | |
| Jan 2020 | $1.92M | Grant | – | – | |
| Jan 2020 | $301,395 | Grant | – | – | |
| Jan 2020 | $1.07M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Helmholtz Munich
Helmholtz Munich has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Helmholtz Munich
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Helmholtz Munich
27 people are tracked at Helmholtz Munich (10 in leadership, 17 in team).
| Name | Role | Group |
|---|---|---|
Matthias H Tschop | CEO | Leadership |
Matthias Hebrok | Director, Institute For Diabetes And Organoid Technology (idot) | Leadership |
Iris Fischer | Head Of Operations (institute Of Translational Genomics) | Leadership |
Alf Wachsmann | Head Of Digit Infrastructure & Scientific Computing | Leadership |
Heck Susanne | Head Of Core Facilities | Leadership |
Anna Seidinger | Head Of Communications & Strategic Relations | Leadership |
Matthias H. Tschöp | CEO | Leadership |
Inti Alberto de la Rosa Velázquez | Head Of The Genomics Core Facility | Leadership |
Susanne Kublik | Head Of Laboratory | Leadership |
Benjamin Sohn | Head Of Digital Transformation & IT | Leadership |
Carlos Garcia | Senior Manager Digitalization | Team |
Xose Luis Dean Ben | Post-doctoral Fellow | Team |
Julia Schlehe | Science Manager | Team |
José Terrón Bautista | Postdoctoral Scientist | Team |
Dr. Martina Mangold-Troup | Senior Manager Digitalization | Team |
Verena Coscia | Team Leader Corporate Communication & Press Officer | Team |
Serene Lee | Scientific Writer / Publication Manager | Team |
Angela Jurik-Zeiller | Science And Project Manager Computational Health Center | Team |
Jenny Hankinson | Project Manager Core Facilities Scientific Management | Team |
Dr. Raffael Ott | Lead Scientist | Team |
7 more people are available in the full profile.
Complete people profiles for Helmholtz Munich
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Helmholtz Munich
3 dated milestones of Helmholtz Munich across 62 years, from founding to its latest funding, stage changes and deals.
- Founded Helmholtz Munich is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $174K.
Web traffic of Helmholtz Munich
The website of Helmholtz Munich (helmholtz-munich.de) receives about 94.8K visits a month.
- Monthly visits94.8K
▼ 13.4% vs previous month
Websites whose visitors overlap most with Helmholtz Munich. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
hmgu.sharepoint.com | hmgu.sharepoint.com | 100% | – | – | – |
| biorxiv.org | 100% | 3M | #19,954 | View details | |
| institut-curie.org | 92% | 75.9K | #525,248 | View details | |
| nature.com | 90% | 33.6M | #1,922 | View details | |
| cell.com | 89% | 5M | #14,619 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Helmholtz Munich
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as Helmholtz Munich (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | 252 | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Helmholtz Munich
Helmholtz Munich was founded in 1960 and raised its 1st funding round 49 years after it was founded.
Helmholtz Munich is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Matthias H Tschop is the current CEO of Helmholtz Munich.
Helmholtz Munich, established in 1960, excels in providing healthcare solutions, and medical research labs. Provider of medical research lab and services. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Helmholtz Munich offers Diabetes Research and Environmental Health Analysis.
Helmholtz Munich has 1 investor. Key investors include European Union.
Helmholtz Munich operates through Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh).